A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186
Clinical trial NCT05694741 · TERMINATED
Trial details
- NCT number
- NCT05694741
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-20
- Primary completion
- 2023-05-10
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.